The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 345:1022-1029 October 4, 2001 Number 14
NextNext

Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes
Antoni Bayes-Genis, M.D., Cheryl A. Conover, Ph.D., Michael T. Overgaard, Ph.D., Kent R. Bailey, Ph.D., Michael Christiansen, M.D., David R. Holmes, Jr., M.D., Renu Virmani, M.D., Claus Oxvig, Ph.D., and Robert S. Schwartz, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Editorial
 by Rabbani, L. E.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Circulating markers indicating the instability of atherosclerotic plaques could have diagnostic value in unstable angina or acute myocardial infarction. We evaluated pregnancy-associated plasma protein A (PAPP-A), a potentially proatherosclerotic metalloproteinase, as a marker of acute coronary syndromes.

Methods We examined the level of expression of PAPP-A in eight culprit unstable coronary plaques and four stable plaques from eight patients who had died suddenly of cardiac causes. We also measured circulating levels of PAPP-A, C-reactive protein, and insulin-like growth factor I (IGF-I) in 17 patients with acute myocardial infarction, 20 with unstable angina, 19 with stable angina, and 13 controls without atherosclerosis.

Results PAPP-A was abundantly expressed in plaque cells and extracellular matrix of ruptured and eroded unstable plaques, but not in stable plaques. Circulating PAPP-A levels were significantly higher in patients with unstable angina or acute myocardial infarction than in patients with stable angina and controls (P<0.001). A PAPP-A threshold value of 10 mIU per liter identified patients who had acute coronary syndromes with a sensitivity of 89.2 percent and a specificity of 81.3 percent. PAPP-A levels correlated with levels of C-reactive protein and free IGF-I, but not with markers of myocardial injury (troponin I and the MB isoform of creatine kinase).

Conclusions PAPP-A is present in unstable plaques, and circulating levels are elevated in acute coronary syndromes; these increased levels may reflect the instability of atherosclerotic plaques. PAPP-A is a new candidate marker of unstable angina and acute myocardial infarction.


Source Information

From the Division of Cardiovascular Diseases (A.B.-G., D.R.H., R.S.S.), Endocrine Research Unit (C.A.C.), and Statistics Department (K.R.B.), Mayo Clinic and Foundation, Rochester, Minn.; the Department of Molecular and Structural Biology, University of Aarhus, Aarhus, Denmark (M.T.O., C.O.); the Department of Clinical Biochemistry, Statens Serum Institute, Copenhagen, Denmark (M.C.); and the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, D.C. (R.V.).

Address reprint requests to Dr. Schwartz at the Division of Cardiovascular Diseases, Mayo Clinic, 200 First St., SW, Rochester, MN 55905.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.